Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 1—January 2024
Research

Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016–2022

Pan Fu1Comments to Author , Jinlan Zhou1, Chao Yang, Yaxier Nijiati, Lijun Zhou, Gangfen Yan, Guoping Lu, Xiaowen ZhaiComments to Author , and Chuanqing WangComments to Author 
Author affiliations: National Children's Medical Center, Shanghai, China (P. Fu, J. Zhou, Y. Nijiati, L. Zhou, G. Yan, G. Lu, X. Zhai, C. Wang); Chinese Academy of Sciences, Shanghai (C. Yang)

Main Article

Figure 1

Distributions of pertussis patients in different age groups, Shanghai, China, 2016–2022. Pertussis was primarily detected from infants (0–1 years of age) before 2020 but mostly from older children and adolescents (>5–10 years of age) after 2020.

Figure 1. Distributions of pertussis patients in different age groups, Shanghai, China, 2016–2022. Pertussis was primarily detected from infants (0–1 years of age) before 2020 but mostly from older children and adolescents (>5–10 years of age) after 2020.

Main Article

1These first authors contributed equally to this article.

Page created: November 19, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external